text:
INFORMATION FOR USERS OF THE WEBSITE
(includes the processing of navigation data and cookies)
Tenute Piccini Spa, with registered office in Località Piazzole 53011 Castellina in Chianti (SI) VAT NR. 00368360525, as Data Controller
Informs
users who connect to the website www.tenutepiccini.it Owner, acquired from third parties or spontaneously conferred by interested parties, will be treated lawfully and according to fairness, in compliance with the principles enshrined in EU and Italian law. The main rules governing the processing of personal data are the European Regulation 679/2016 and the Legislative Decree 196/2003, as amended by Legislative Decree 101/2018.
Interested party Natural person to whom the data processed by the owner or manager belong
Data controller The natural or legal person, public authority, service or other body which, individually or together with others, determines the purposes and means of processing personal data
Responsible The natural or legal person, public authority, service or other body that processes personal data on behalf of the data controller on the basis of a contract that governs the conditions of the assignment
The processing activities of the data collected through the website are carried out by the Data Controller at the company's offices, in compliance with the security measures and provisions imposed by the European Regulation 679/2016, by subjects appointed by it or delegated (specifically selected and equipped of the necessary professionalism), with manual and computerized procedures, to allow the user a simple and rewarding browsing experience, to collect useful elements to improve the offer of products and services via the web, to execute specific requests of the interested party , for pre-contractual and contractual obligations, for ordinary administrative, financial and accounting activities, to manage customer requests during the marketing and sale of products or the provision of services, for after-sales assistance, for the fulfillment of legal obligations.
The processing is also aimed to the processing of anonymous statistics or after a pseudonymisation procedure. At the request of the interested party or after obtaining specific consent, the processing may also be carried out for the detection of the degree of satisfaction, tastes, preferences and habits of the customer, for the sending of commercial information or advertising material, for direct marketing campaigns, for the issue of fidelity cards connected to particular conditions of sale, for participation in games, competitions or prize operations, for involvement in events and exhibitions, for the provision of services, for market research and other operations directly or indirectly attributable to marketing activities. Other data may be forwarded to the Data Controller by the Data Subject for the possible establishment of employment relationships or commercial collaboration.
Data subject to processing
Navigation data Common IP address, operating system and browser used for navigation, date and time of connection and disconnection, time spent on the site, pages visited, activity carried out, location (if the related service is active) and any other information made available or transmitted by device of the interested party, based on the chosen security settings.
Contacts Common Name, surname, e-mail address, other data sent by the interested party to the email addresses of the owner or through the preset forms.
Partnership Common Name, surname, e-mail address, telephone and postal numbers, other information useful for the possible establishment of the commercial collaboration relationship.
The compilation of the forms on the website, to receive information on products and services, involves the acquisition of the customer's data in the computer system of the Data Controller. The information is protected by an authentication system and can only be reached by those in possession of the relevant credentials. In other cases, the procedure generates an e-mail message addressed to the Data Controller, which is found based on the requests of the interested party. Communications by e-mail involve the storage of the interested party's e-mail address, which is necessary to respond to the requests made. This includes the data stored in the message. The Data Controller suggests not to transmit the data or personal information of third parties, unless it is absolutely necessary.
Data of Minors
The data of minors are processed exclusively with the consent of their parents and within the limits imposed by law, without prejudice to the provisions of art. 2-quinquies, Legislative Decree 196/2003, as introduced by Legislative Decree 101/2018. The Owner will not be in any way responsible for any false declarations that may be provided by minors and, should he ascertain the falsity of the declaration, he will immediately delete any personal data and any information acquired.
Nature of the provision
The processing of contact data is essential to meet the requests of the interested party and fulfill contractual obligations. The conferment is therefore necessary, since it cannot be processed otherwise. Any incorrect or insufficient communication of the requested data may result in the total or partial impossibility of executing the requests of the interested party and the possible mismatch of the results of the processing with the agreements made or with the obligations imposed by rules and regulations. Further information may be necessary for the purposes of personnel selection (professional training, previous work experience) and commercial collaboration (previous work experience, financial solvency).
Other data, on the other hand, are collected for the sole purpose of adapting navigation, promotional campaigns, offers, production and stocks, as well as, in general, company activity, to the tastes and interests of customers. Their provision, therefore, is not mandatory and any refusal to process or the revocation of consent already given does not affect the establishment and continuation of the main relationship.
Legal bases of the processing carried out by the Data Controller are the obligations relating to the pre-contractual and contractual phases of the relationship, the obligations imposed by law, the legitimate interest of the Data Controller to manage the data necessary to improve the offer of products and services, the consent expressed by the interested parties . It is possible to ask the Data Controller to specify the legal basis of each treatment.
Retention terms
The data processed by the Data Controller, without prejudice to legal obligations, are kept until an express request for cancellation by the interested party and in any case periodically verified, also with automatic procedures, in order to guarantee their updating and effective compliance with the purposes. of the treatment. If the purpose for which they were acquired has ceased, the data will be deleted, unless they must be processed to comply with regulatory obligations, to protect rights in court or at the express request of the interested party (10 years from the termination of the relationship, 12 months for CVs). At the end of the processing and following the cancellation, the rights of the interested party can no longer be exercised.
Browsing data
The IT system and the software used for the corporate web portal acquire, during their normal operation, some personal data whose transmission is implicit in the use of Internet communication products: IP addresses and domain names of the computer used by the user to connect to the site, URL (Uniform Resource Locator) of the requested resource, time of the request, method used to send the request to the server, size of the file received, numeric code used to indicate the status of the response given by the server (executed or error, etc.) and other parameters relating to the operating system and the user's computer. This information is not stored to identify the data subjects but, due to its nature, can, through processing and association with other data, allow the identification of the user. They are used to create anonymous statistics on the use of the site and to check its correct functioning. They are usually deleted immediately after processing. They can be used and provided to law enforcement and the judiciary to ascertain responsibility in the event of damage to the site or offenses perpetrated through the network.
Some information regarding navigation is stored on the customer's computer and read by the system at the next connection. This file, called "cookie" contains data that is not of a personal nature, as it does not allow specific identification of the user, but can allow it through the interconnection with other data. The information contained in the cookies allows you to see the frequency of visits to a site and the activity carried out during navigation. In this way, over time, it is possible to improve the content of the site and make it easier for the user to use. Even companies that transmit content to the site or whose sites are accessible via links can use cookies when the user selects the relevant link. In these cases, the use of cookies is not under the direct control of the Data Controller. Most browsers automatically accept cookies, but you can reject them or select only some of them, according to the preferences set by the user. However, if the user inhibits the loading of cookies, some components of the site may stop working and some pages may be incomplete.
Essential technical cookies:Cookiescriptacceptdadaproaffinity These are cookies necessary to ensure a correct and fluid functioning of the site: they allow the navigation of the pages, the sharing of contents, the storage of access credentials to speed up entry to the site and to keep preferences active while browsing , facilitating the browsing or shopping experience. Without these cookies it is not possible to provide, in whole or in part, the services for which users access the site.
Statistical cookies:_utma_utm_utmc_utmt_utmaz They allow us to understand how users use the site in order to then evaluate and improve its operation, in order to create increasingly appropriate content. They allow you to know which pages are the most and least frequented, how many visitors to the site are, how much time is spent on the site by the average user and how visitors arrive on the site. In this way it is possible to determine which are the optimal functioning and the most liked contents and how the contents and functionality of the pages can be improved.
Analysis cookies They are used to keep track of the searches made by the user in order to be able to submit products and services that comply with previous browsing and searches. They are normally used for remarketing operations, through which advertising relating to consultations already made and similar products and services is conveyed to the user while browsing.
Profiling cookies They are suitable tools for memorizing the choices made by the user during navigation and consultation, in order to create personal profiles capable of classifying and filing tastes, preferences, browsing and consumption habits. Through the generation of these profiles, the user's browsing experience can be improved, but above all it can be oriented to their preferences, abilities and the possibility of purchasing or using services. They can be deactivated without creating any obstacle or impediment to navigation.
Third party cookies:_fbp They are cookies used by third parties not directly controlled by the Owner. The company cannot provide guarantees with respect to the use that will be made of the data, the processing of which is directly operated by an external partyCookies from third party operators allow you to offer advanced features, more information and personal functions, including the ability to share content through social networks and have a personalized site experience based on the preferences expressed through the pages visited.If these external services are used, the provider may be able to know that the user has visited the site of the owner. The use of the data collected by these external operators is subject to the data protection policies of the same. Third-party cookies are identified with the names of the respective operators and can be disabled.
By selecting the OK button shown by the overlay banner, you authorize the installation of cookies on the device used by the interested party. You can change the cookie settings using the specific selectors or through the browser functions. You can prevent the installation of third-party cookies and remove previously installed cookies, including those containing tastes, habits and preferences. To adjust or change the browser settings, you need to consult the software or application manufacturer's guide. Information on how to manage cookies on your browser is available at the following addresses: Google Chrome, Mozilla Firefox, Apple Safari, Microsoft Internet Explorer, Microsoft Edge. More information on the cookies used by the site can be requested directly from the Data Controller
The site, even if only periodically, may contain links to third-party sites and applications (Google Adwords, Analitycs, Youtube, Vimeo, etc.), to provide additional services and information to the user. When the user uses these links, he leaves the company website and accesses other resources that are not under the direct control of the Data Controller, who, therefore, will not be responsible for the procedures relating to navigation, security and data processing. personal data operated by other sites, even in the presence of co-branding or display of the company logo. A careful examination of the security and confidentiality procedures of the visited site is recommended, which may transmit additional cookies, read those already on the user's hard drive and request / acquire additional personal information.
Newsletter management services
The newsletter, if present, is managed by software that uses a database of email addresses to send communications to registered users (through the appropriate section of the site) and which provides for an automatic cancellation procedure that the interested party can use independently, recalled from any communication sent by this instrument.
Forms for the search of personnel
They acquire the information necessary for an initial evaluation of the candidate to decide whether to call him for an interview and for the examination of the actual correspondence to the position he should hold in the company. Normally a series of standard information (name, surname, telephone and postal addresses, telematic addresses, level of education and previous work experience) is associated with the CV prepared and produced by the candidate. If the selection is successful, the data are transmitted to the competent office for recruitment, otherwise they are kept for a period deemed appropriate with respect to the necessary updating by the candidate
Forms for finding partners and franchisees
They acquire the information necessary for an initial assessment of the business partner and the current activity carried out, in order to make a selection before the interviews aimed at signing the contract.
Interaction with social networks and external platforms
The site, through widgets and buttons, can interact with external platforms and social networks. In this case, the information acquired depends on the settings of the profiles used by the user and not by the Owner.
The buttons "Like" of Facebook, "Tweet" of Twitter "," Recommend "of Linkedin, etc., allow you to share the pages or topics of the site with the respective social platforms and acquire data of the interested party. More information can be obtained from the websites of the companies offering the service. In this case, the data are not managed by the owner's website, which connects these buttons only to offer an additional service to the interested party but has no control over them.
Automated decision-making processes
The Owner does not use automated decision-making processes.
Communication and dissemination
The data processed through the site are exclusively of a common nature and are not intended for dissemination. The Data Controller does not require and has no interest in detecting and processing data classified by the Regulation as "particular" (health, genetic, biometric, etc.) or "criminal", without prejudice to legal obligations and the acquisition of curricula through the section "Work with us" or sent spontaneously by the interested party via email (which will in any case be treated in compliance with the rules on the management of the established or potential employment relationship).
The data will be disclosed to third parties, who may assume, based on the type of relationship, the status of data controller pursuant to art. 28, EU Reg. 679/2016 or of mere recipients of the communication, for activities related to or deriving from that of the Data Controller or in the fulfillment of obligations deriving from laws or regulations (Institutions, Law Enforcement, Judicial Authorities, etc.). By way of non-exhaustive example, the following are mentioned:
Subjects who need to know the data of the interested party for purposes relating to the relationship with the Data Controller (credit institutions, insurance companies, financial intermediaries, electronic money institutions and payment management, credit recovery companies, customer verification companies, communication company, etc.);
Consultants, collaborators, service companies, within the limits necessary to carry out the assignment conferred by the Owner;
Subsidiary and / or associated companies that can access the data, within the limits strictly necessary to carry out tasks entrusted by the Data Controller;
Post offices, couriers, transporters;
The updated list of data processors is available at the headquarters of the Data Controller.
Transfer abroad
The data whose conferment is optional may, within the limits of the consent signed or the contractual agreements stipulated by the Data Controller, be communicated to subjects operating within the European Union or in countries that guarantee the same level of protection required by the European Regul ation 679 / 2016.
Rights of the interested party
The rights referred to in Articles. from 15 to 22 of the GDPR 679/2016. In particular, the interested party has the right to access their data (Article 15) to request its correction, updating, integration (Article 16) and cancellation (Article 17), to limit its use. by the Data Controller (Article 18), to obtain a copy in a structured format, commonly used and readable by an automatic device (Article 20), to oppose the processing by fulfilling the conditions (Articles 21 and 22). The rights can be exercised to the extent that the processing is not required by law or regulation. Applications relating to the exercise of the rights of the interested party can be forwarded to the Data Controller at the address privacy@tenutepiccini.it. If the interested party is not satisfied with the response provided to his requests, he can lodge a complaint with the Guarantor Authority for the protection of personal data. Citizens of another member state of the European Union have the right to contact the supervisory authority of their country.
© 2020 ASTRALE. All Rights Reserved


return of the ever popular annual holiday exhibition, now in its 38th year.
Jacob Blauvelt House, c. 1832 (on the National Register of Historic Places).
In addition to selecting interesting, eclectic and unique items from the HSRC's collection shelves, Ned Kelly and his team will decorate the historic Jacob Blauvelt House using their "perfect-pitch taste," enhancing the charming spaces with exquisite beauty and refined elegance for the holidays.
Opportunities to view the "Simple Gifts" exhibition and the holiday décor will be during the Society's Holiday Programs, on Saturdays and Sundays from 12noon to 4pm and by appointment on weekdays between December 14 and January 12.
Candlelight Tours of the Jacob Blauvelt House: Sundays, December 29, and January 5 and 12. Tours begin promptly at 5 and 6:30 pm. Prepaid reservations required. For information, click here.


text:
Home » Avatar, The Last Airbender: The Rise of Kyoshi (Exclusive Edition) (Hardcover)
Avatar, The Last Airbender: The Rise of Kyoshi (Exclusive Edition) (Hardcover)
By F. C. Yee, Michael Dante DiMartino (Other primary creator)
Outside of writing, F. C. Yee practices capoeira, a Brazilian form of martial arts, and has a day job mostly involving spreadsheets. His debut YA novel, The Epic Crush of Genie Lo, released in August 2017 to critical acclaim. He lives and writes in Denver. The Shadow of Kyoshi was written in consultation with Michael Dante DiMartino, the co-creator, executive producer, and story editor of the animated TV series Avatar: The Last Airbender and The Legend of Korra.
Publisher: Harry N. Abrams
Young Adult Fiction / Media Tie-In
Compact Disc (July 21st, 2020): $118.00

redpajama_set_name: RedPajamaCommonCrawl


An Educational platform for Preparation and Practice Class 8. Kidsfront provide unique pattern of learning English with free online comprehensive study material in the form of QUESTION & ANSWER for each Chapter of English for Class 8. This study material help Class 8, English students in learning every aspect of Active and passive voice . Students can understand Active and passive voice concept easily and consolidate their learning by doing Online Practice Tests on English,Active and passive voice chapter repeatedly till they excel in Class 8, Active and passive voice . Free ONLINE PRACTICE TESTS on Class 8, Active and passive voice comprise of Hundreds of Questions on Active and passive voice , prepared by the highly professionals team. Every repeat test of Active and passive voice will have new set of questions and help students to prepare themselves for exams by doing unlimited Online Test exercise on Active and passive voice . Attempt ONLINE TEST on Class 8,English,Active and passive voice in Academics section after completing this Active and passive voice Question Answer Exercise.
Topic wise:Active and passive voice preparation in the form of QUESTION & ANSWER.
Evaluate preparation by doing ONLINE TEST of Class 8, English,Active and passive voice .
Attempt repeat ONLINE TESTS of English Active and passive voice till you excel.


text:
Manuscript Alternation Service
Join as Editor
Clinical Image
Language Editing Service
Authorship Creteria
Charges, Waiver and Withdrawal
Informed Concent & Ethics
J HIV Clin Sci Res
Journal of HIV for Clinical and Scientific Research
Research Article Open Access Peer-Reviewed
Predictors of mortality among adult patients enrolled on Antiretroviral Therapy in Hiwotfana specialized University Hospital, Eastern Ethiopia: Retrospective Cohort study
Endalkachew Mekonnen Eticha1* and Ashenafi Beru Gemeda2
1Department of Pharmacy, College of Health and Medical Science, Haramaya University, Harar, Ethiopia
2Department of clinical nursing, college of Medicine and Health Science, Jigjiga University, Jigjiga, Ethiopia
*Corresponding author: Endalkachew Mekonnen Eticha, Department of Pharmacy, College of Health and Medical Science, Haramaya University, Harar, Ethiopia, Tel: +251967344420; E-mail: obsaamiiraa@gmail.com
DOI: 10.17352/2455-3786.000027
Received: 10 September, 2018 | Accepted: 09 November, 2018 | Published: 10 November, 2018
Keywords: HIV patients; ART; Predictors; Mortality
Eticha EM, Gemeda AB (2018) Predictors of mortality among adult patients enrolled on Antiretroviral Therapy in Hiwotfana specialized University Hospital, Eastern Ethiopia: Retrospective Cohort study. J HIV Clin Sci Res 5(1): 007-011. DOI: 10.17352/2455-3786.000027
Objective:Mortality of HumanImmunodeficiency Virus (HIV)- infected patients have been reduced substantially since the introduction of Antiretroviral Therapy (ART). However, many studies have shown high mortality. But the factors associated with this high mortality are poorly characterized. So this retrospective cohort study aims to determine mortality and identify predictors of it among patients on ART at Hiwotfana specialized university Hospital (HFSUH).
Result: A total of 61 (11.9%) deaths were observed giving an overall mortality rate of 2.8 per 100 person years. Advanced WHO stages (hazard ratio (HR) =3.44, 95% CI: 1.73 - 6.85), baseline CD4 count less than 200cells/mm3 (HR=3.18, 955 CI: 1.671- 6.06), regimen changed (HR=23.62, 95% CI: 9.95 - 56.05), and being anemic (HR=3.23, 95% CI: 1.71 - 6.11) were the independent predictors of mortality. Patients who started AZT based initial regimen had a lower risk of mortality (HR=0.29, 95% CI=0.13 - 0.64) when compared with the D4T based regimen.
Main article text
Globally, the number of people living with human immunodeficiency virus (HIV) reached 38.8 million in 2015(1). Ethiopia is one of the sub-Saharan African countries hardest hit by the HIV epidemic. In Ethiopia, there were 786,040 HIV-infected people, 39,140 new HIV infections and 28,650 HIV/AIDS deaths in 2015 [1].
There has been a dramatic decline in morbidity and mortality in patients with HIV disease in all demographic sub-populations with the advent of highly active antiretroviral therapy (HAART) [2-4]. Global mortality peaked in 2005 at 1.8 million and subsequently fell by 5·5% per year to 1.2 million in 2015 [1]. According to UNAIDS/Ethiopia report, approximately 20,000 HIV related deaths [5]. Despite the increased availability of ART and promising efficacy, early mortality has been high after initiating ART [6,7]. Factors contributing to the high fatality rate and reduced quality of life in poor countries are poorly understood.
Multiples of factors have been associated with mortality among clients on ART [7-10]. However, those factors which contribute to the deaths of HIV-infected patients while on ART are not well explored particularly in eastern Ethiopia. Therefore, this study aimed to investigate the predictors of mortality among adult ART users in HFSUH, eastern Ethiopia.
Study period, setting and participants
The present study was conducted from January to June 2016 in HFSUH located eastern part of Ethiopia. The hospital starts ART service in 2005 and since then it has been providing, free of charge ART to eligible HIV-infected patients.
The treatment protocol for Ethiopia is implemented using World Health Organization (WHO) ART treatment guideline for HIV infection in adults and adolescents [11] and national guidelines for HIV prevention, care and treatment: Federal Democratic Republic of Ethiopia [12]. According to the current treatment guidelines, HIV infected adults are eligible to start ART if their CD4cell count is < 500cells/mm3 irrespective of CD4 count or WHO clinical stage 3 or 4 irrespective CD4 cell count. Breast feeding women, pregnant women, and sero-discordant couples can start ART irrespective of CD4 cell count. For all HIV-infected children below 15 years of age, ART is recommended irrespective of WHO clinical stage and CD4 cell count.
A retrospective cohort study was conducted from January to June 2016 on treatment-naïve adult patients who enrolled on ART from 2005 to December 2015. Sample size calculation was done based on the assumption that the type I error of 5%, power by 80% and the exposure variable is CD4 count less than 200cells/mm3 (HR =5.4) which gives the maximum sample size among significant predictors collected from relevant literatures. Based on this, random sample of 513 patient's medical records was drawn for data collection. Regarding the sampling technique, patients' medical card numbers were generated from the computer database according to their entry time and adult patients were filtered using eligibility criteria, then we give a unique number for the remaining records and select each record for our study using systematic random sampling. Pregnant women started ART for prevention of mother to child transmission (PMCT), regimen change, and transfer in were excluded from the study.
Data collection and quality control
A Standard checklist containing study variables were developed from the patient registry card which was developed by the Ethiopian Federal Ministry of Health (FMOH). During data collection, the most recent laboratory results before starting ART were generally used as baseline values. If there is no pre-treatment laboratory test, however, the results obtained within one month of ART initiation were used. The data collection/extraction process was supervised by the principal investigator. Two trained data collectors were involved in the study; both were nurses working in the ART clinic. All completed data were examined for clarity and consistency on a daily basis.
Study variables and measurements
Patients' survival time (time to death) was the outcome variables of this study. In some patients who lacked the time of death, the last follow up time was used. Mortality/death was defined as any recorded AIDS-related deaths, including deaths due to opportunistic infections secondary to delayed ART initiation, treatment failure and poor adherence to both ART regimen and prophylactic antibiotics.
The independent variables include: age, sex, marital status, past opportunistic infection (OI), baseline WHO clinical stages, baseline CD4 counts, nutritional status (measured by body mass index (BMI)), baseline opportunistic infection, IPT status, initial HAART, Hemoglobin level (Patients were called anemic if the hemoglobin level is (<12mg/dl)), HIV/TB co-infection, Isoniazed prophylaxis therapy (IPT) status, and regimen change. Regimen change excludes transfer-out and defaulters.
The collected data were cleaned, categorized, coded, entered and analyzed by using STATA 12. Kaplan-Meier survival analysis was used to estimate survival probability. We applied Cox-proportional hazards regression to identify risk factors associated with outcome variable (time of regimen change). Variables found to be associated with the outcome in the univariate analysis assuming a significance threshold of 20% were included in the multivariate analysis. The multivariate analysis results showed a significant effect on the outcome considering the significance thresholds of 5% were described.
Ethical clearance was obtained from Ethical clearance board of Haramaya University, college of Health and Medical science (reference number sop 792/1/2016) and data access permission was obtained from the medical director of HFSUH. We simply extracted anonymized data from the patient's medical registry and no participant was involved in the study.
Characteristics of study participants
A total of 513 patients medical records were used to extract the information. The socio-demographic characteristics of the cohort are summarized in table 1. The mean age of the patients was 34.75 +7.19 years. Up on enrolment, 48.34% of the patients were in WHO clinical stage III or IV and the mean CD4 count were 221 cells ⁄mm3 (+111.32). The initial HAART regimens were changed for 251(48.93%) of the patients during the follow up period.
Table 1: Baseline factors of HIV-infected patients on initial HAART at Hiwotfana Specialized University Hospital from 2005 to June 2016, eastern Ethiopia.
Variables Alive (n) Dead (n) Total (N)
Mean Age, years + SD 34.75+ 7.19
Female 267 34 301
Male 185 27 212
Underweight (<18.5) 195 41 236
Normal (18.5 - 25) 236 17 253
Above weight(>=25 -30) 16 2 18
Obese (>=30) 4 1 5
WHO stages
Stage I &II 251 14 265
Stage III&IV 201 47 248
CD4 count(cells/mm3)
<200 170 48 218
>200 282 13 295
IPT status
Not took 177 49 226
Took 274 12 286
Active HIV/TB co-infection
No 397 43 440
Yes 55 18 73
Regimen change
Yes 240 11 251
HAART regimen
D4T-based 176 20 196
AZT-based 122 13 135
TDF-based 153 28 181
Anemic status
Non-anaemic 206 48 254
Anemic 208 12 220
iIPT, Isoniazid prophylaxis therapy, WHO clinical stage I indicates asymptomatic and persistent generalized lymphadenopathy; WHO clinical Stage 3 was defined if one of the following is present: weight loss of >10% body weight, chronic diarrhea for >1 month, fever for >1 month, oral candidiasis, or pulmonary Tb within the previous year, or severe bacterial infections; WHO clinical Stage 4 was defined if one of the following is present in an HIV diagnosed patient: HIV wasting syndrome, PCP, toxoplasmosis of the brain, cryptosporidiosis with diarrhea for >1 month, cytomegalovirus disease, herpes simplex virus infection, progressive multifocal leukoencephalopathy, candidiasis, extra-pulmonary Tb, lymphoma, kaposi's sarcoma.
Prevalence and trends of mortality
Patients were followed for a total of 2123.9 person years (PY) with a median follow up of 48.48 months. The overall mortality rate was 2.8 per 100 PY of follow-up (95% CI=2.22 - 3.69). In this cohort, 11.9% (n=61) of the patients were died, most of the deaths, 27 (44.26%), occurring within the first six months. The estimated survival probability at 6, 12, 18 and 24 months were 94.6%, 93.5%, 92.3% and 89.7%, respectively.
Predictors of mortality
The results from the multivariable Cox proportional hazards regression analysis found patients who were on WHO clinical stage III or IV (HR=3.44, 95% CI: 1.73 - 6.85), regimen changed (HR=23.62, 95% CI: 9.95 - 56.05), baseline CD4 count less than 200 cells/mm3 (HR=3.18, 955 CI: 1.671- 6.06) and anemic patients (HR=3.23, 95% CI=1.71 - 6.11) had higher odds of death compared with their respective counterparts shown in table 2. Patients who started AZT based initial regimen had 71% less risk of mortality (HR=0.29, 95% CI=0.13 - 0.64) when compared with the D4T based regimen.
Table 2: Hazard ratios of mortality according to baseline variables in HIV-infected patients starting HAART in Hiwotfana Specialized University Hospital from 2005 to June 2016, eastern Ethiopia.
Variables Unadjusted HR p-value Adjusted HR P-value
WHO clinical stages (vs. I &II)
Stage III & IV 3.16 (1.74 – 5.75) 0.000 3.44(1.73 - 6.85) 0.000
CD4 count (cells/mm3)( vs. >200)
<200 4.47(2.42 - 8.28) 0.000 3.18(1.671- 6.06) 0.000
TB status (vs. Negative)
Positive 2.44 (1.41- 4.24) 0.001 0.88(0.48 - 1.62) 0.683
Regimen changed(vs. No)
Yes 8.87(4.46 - 17.67) 0.000 23.62(9.95-56.05) 0.000
Initial HAART (vs. D4T-based)
AZT- based 1.29(0.63 - 2.62) 0.489 0.29(0.13 - 0.64) 0.002
TDF-based 3.31 (1.77 – 6.19) 0.000 0.55(0.27 - 1.13) 0.103
Anaemic status(vs. non-anaemic)
Anemic 3.73(1.98 - 7.02) 0.000 3.23(1.71 - 6.11) 0.000
This 10-year retrospective cohort study of HIV/AIDS patients on HAART gives an insight into survival and its predictors in hospital settings in Ethiopia. In this cohort, 1/10th (11.9%) of the patients died and the majority of the deaths (44.26%) occurred within the first six months. Studies from other parts of Ethiopia, Shashamane referral hospital, Jinka hospital and Ethiopian Somali region reported comparable results, 10.3%, 10%, 11.1% respectively [13-15]. In contrary, studies from other regions of Ethiopia, Nekemte Referral Hospital (7.2%) and Aksum Hospital (8.85%) reported lower mortality [9,16].
The estimated survival probability of our cohort at 6, 12, 18 and 24 months were 94.6%, 93.5%, 92.3% and 89.7%, respectively. This shows a better survival compared with Ethiopian Somali [13] and Malawi studies [20]. This better survival in our cohort group may be due to majority of this cohort started HAART at WHO stage I or II (51.66%) and at a CD4 count > 200 cells/mm3 (57.5%).
Previous studies done in Ethiopia show that advanced WHO clinical stage was one of the major predictors of mortality for patients enrolled on ART [17-19]. This study was consistent with those findings. A Cohort study from Cameroon [20], indicated patients with stage III (2 times) and stage IV (3.79 times) more likely to die than patients with stage I or II. Previous studies in Africa, Tanzania, South Africa and Senegal [7,21,22] also showed that advanced stage of the disease was associated with more than doubling in the hazard of death.
In this cohort study, clients with baseline CD4 count < 200 cells/mm3 had higher hazard of mortality than patients with CD4 count >200 cells/mm3. Cohort study in university of Gondar indicated patients presented with CD4 count < 200cells/mm3 had 5 times higher risk of mortality than those with >200cells/mm3 [23]. In line with the present study, different studies found twice or more risk of mortality among patients with CD4 count of < 200 cells/mm3 (7,8,24). Advanced immunodeficiency was associated with opportunistic infection, thereby increasing the likelihood of death.
Patients who were anaemic at baseline were 3 fold higher risk of mortality than those who doesn't have. Previous studies done across many parts of Africa and in industrialized countries reported that anaemia at baseline was independently associated with higher mortality among patients enrolled on ART [7,20,25]. A Similar study from Ethiopia by Tadesse and colleagues [15], mortality was higher among patients with anaemia than their comparator. Although there is no concrete evidence on causal association between anaemia and mortality, the incidence of anemia, increased with the progression of HIV disease [7,26,27].
The initial regimen change was a significant predictor of mortality in this cohort study. Different studies confirm that ART regimen change causes diminishing the clinical and immunological benefit of treatment [28,29] failing virological suppression, increase drug resistance [30] and thereby increase morbidity and mortality due to HIV/AIDS [30,31]. This cohort also showed that patients on Zidovudine based regimens were shown to have less risk of mortality (HR: 0.34; 95% CI: 0.16 - 0.76) than D4T based regimen.
This study has revealed an overall low mortality rate, but the high mortality rate in the first six months of HAART initiation. Advanced WHO stages, lower CD4 count, ART regimen changed, D4T based regimen and anemia were the independent predictors of mortality. For this reason, early enrolment of patients on HIV care service and treatment is very crucial to improve patients' survival.
Limitations of the study
We acknowledge the limitations of the current study, including: 1) This study includes only patients' medical records with complete baseline information, so this might have made a selection bias; 2) all deaths documented were considered as HIV/AIDS related deaths due to lack of available records on the cause of death; 3) it also shares limitations of retrospective studies.
The authors acknowledge HFSUH, College of Health and Medical Science for providing access to the data. We were also grateful for the data collectors and supervisors for the carefully undertaking of their tasks.
No specific funding was received. This study was conducted for the partial fulfilment of a Bachelor of Degree in Pharmacy at School of Pharmacy, College of Health and Medical Science, Haramaya University.
EM: conceived, designed and participated in data collection, conducted the data analysis and interpretation, developed the first draft and revised subsequent drafts. MH: participated on data collection, data analysis and interpretation. TF: reviewed and commented on successive drafts. AB: commented on successive drafts.
Ethical clearance board of Haramay University, College of Health and Medical science, ethically approved all the study methods and protocols and responded with a letter reference number sop792/1/2015. Informed consent was not taken from the patients, as the information was extracted from anonymized data.
Availability of data and material
All relevant data are within the paper. The STATA data of individual patients are not permitted to be provided to other bodies, as indicated on ethical clearance. However, researchers who need further clarification can obtain anonymised data from the corresponding author on reasonable request.
GBD 2015 HIV Collaborators (2016) Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV 3: e361-e87. Link: https://goo.gl/GknZY4
Chan KC, Wong KH, Lee SS (2002) Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002. HIV Med 7: 186-192. Link: https://goo.gl/CouFTm
May M, Boulle A, Phiri S, Messou E, Myer L, et al. (2010) Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet 376: 449-457. Link: https://goo.gl/y7xL5a
Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, et al. (2006) Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296: 782-793. Link: https://goo.gl/TPkCgw
UNAIDS (2016) global-AIDS-update-2016. Link: https://goo.gl/u7HMk9
Ivers LC, Kendrick D, Doucette K (2005) Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis 41: 217-224. Link: https://goo.gl/N9d18z
Johannessen A, Naman E, Ngowi BJ, Sandvik L, Matee MI, et al. (2008) Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis. 8: 52. Link: https://goo.gl/h4H6qe
Biadgilign S, Reda AA, Digaffe T (2012) Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study. AIDS Res Ther 9: 15. Link:
Tadesse K, Haile F, Hiruy N (2014) Predictors of mortality among patients enrolled on antiretroviral therapy in Aksum hospital, northern Ethiopia: a retrospective cohort study. PLoS One 9: e87392. Link: https://goo.gl/Y4nUQ1
Poka-Mayap V, Pefura-Yone EW, Kengne AP, Kuaban C (2013) Mortality and its determinants among patients infected with HIV-1 on antiretroviral therapy in a referral centre in Yaounde, Cameroon: a retrospective cohort study. BMJ Open 3. Link: https://goo.gl/ddVCQx
WHO (2010) Antiretroviral therapy for HIV infection in adults and adolescents. Geneva: WHO, 2010. Link: https://goo.gl/dosaQo
FHAPCO (2014) Country Progress Report on HIV / AIDS: Federal Democratic Republic of Ethiopia. Addis Ababa, Ethiopia 2014 Link: https://goo.gl/MNmUah
Alemu AW, Sebastian MS (2010) Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia. Glob Health Action 3. Link: https://goo.gl/eXSkfZ
Damtew B, Mengistie B, Alemayehu T (2015) Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia. Pan Afr Med J 22: 138. Link: https://goo.gl/YkRFe6
Tachbele E, Ameni G (2016) Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital, South Omo, Ethiopia: a six years retrospective cohort study. Epidemiol Health 38: e2016049. Link: https://goo.gl/tNKZEr
Hambisa MT, Ali A, Dessie Y (2013) Determinants of Mortality among HIV Positives after Initiating Antiretroviral Therapy in Western Ethiopia: A Hospital-Based Retrospective Cohort Study. ISRN AIDS 2013: 491601. Link: https://goo.gl/NvwusR
Tadele A, Shumey A, Hiruy N (2014) Survival and Predictors of Mortality among Adult Patients on Highly Active Antiretroviral Therapy at Debre-Markos Referral Hospital, North West Ethiopia; A Retrospective Cohort Study. J AIDS Clin Res 5: 280. Link: https://goo.gl/vuisvX
Mulissa Z, Jerene D, Lindtjorn B (2010) Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia. PLoS One 5: e13268. Link: https://goo.gl/vtFRvZ
Setegn T, Takele A, Gizaw T, Nigatu D, Haile D (2015) Predictors of Mortality among Adult Antiretroviral Therapy Users in Southeastern Ethiopia: Retrospective Cohort Study. AIDS Res Treat 2015:148769. Link: https://goo.gl/2fbDFz
Sieleunou I, Souleymanou M, Schonenberger AM, Menten J, Boelaert M (2009) Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health 14: 36-43. Link: https://goo.gl/o3WF54
Etard JF, Ndiaye I, Thierry-Mieg M, Gueye NF, Gueye PM, et al. (2006) Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 20: 1181-1189. Link: https://goo.gl/w9mftC
Lawn SD, Myer L, Orrell C, Bekker LG, Wood R (2005) Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 19: 2141-2148. Link: https://goo.gl/tkk4fb
Wubshet M, Berhane Y, Worku A, Kebede Y, Diro E (2012) High loss to followup and early mortality create substantial reduction in patient retention at antiretroviral treatment program in north-west Ethiopia. ISRN AIDS 2012: 721720. Link: https://goo.gl/szFfYK
Johansson KA, Robberstad B, Norheim OF. Further benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy. AIDS Res Ther 7: 3. Link: https://goo.gl/FAk4rf
Harris RJ, Sterne JA, Abgrall S, Dabis F, Reiss P, et al. (2008) Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. Antivir Ther 13: 959-967. Link: https://goo.gl/Pke9oF
Masaisa F, Gahutu JB, Mukiibi J, Delanghe J, Philippe J (2011) Anemia in human immunodeficiency virus-infected and uninfected women in Rwanda. Am J Trop Med Hyg 84: 456-460. Link: https://goo.gl/2tESQM
Obirikorang C, Issahaku RG, Osakunor DN, Osei-Yeboah J (2016) Anaemia and Iron Homeostasis in a Cohort of HIV-Infected Patients: A Cross-Sectional Study in Ghana. AIDS Res Treat 2016: 1623094. Link: https://goo.gl/5V5oSR
Assefa Y, Lynen L, Wouters E, Rasschaert F, Peeters K, et al. (2014) How to improve patient retention in an antiretroviral treatment program in Ethiopia: a mixed-methods study. BMC Health Serv Res 14: 45. Link: https://goo.gl/QHTdPy
Gesesew HA, Ward P, Woldemichael K, Mwanri L (2017) Prevalence, trend and risk factors for antiretroviral therapy discontinuation among HIV-infected adults in Ethiopia in 2003-2015. PLoS One 12: e0179533. Link: https://goo.gl/mDMNmg
Li X, Margolick JB, Conover CS, Badri S, Riddler SA, et al. (2005) Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 38: 320-328. Link: https://goo.gl/YMiG95
Rosen S, Fox MP (2011) Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 8: e1001056. Link: https://goo.gl/w68XTD
© 2018 Eticha EM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
View Similar Articles
Share your thoughts and experiences
FullText PDF
Order for reprints
Subscribe to our articles alerts and stay tuned.
Submit your next article Peertechz Publications, also join of our fulfilled creators. Submit a Manuscript
© Peertechz Publications Inc., 10880 Wilshire Blvd., Suite 1101, Los Angeles, California, 90024, USA


Distributor Information for KL Biotech Ltd. (Taiwan, P.O.C.) :: Microscopes Intl.
KL Biotech is a group with more than 10 years of life science related technology and sales experience. We are specialized in domestic and foreign experimental reagents, supplies, and equipment to serve the major biotechnology-related industries–including research units, hospital clinics, teaching institutions, students, technology companies, and so on.
Restaurants near KL Biotech Ltd.
Home About Distributors Taiwan, P.O.C. KL Biotech Ltd.


text:
Kyrie Irving Is Becoming a Far-Right Hero for Not Getting the COVID Vaccine
A onetime hero of the Black Lives Matter movement has become an unlikely hero of the far right.
by Trone Dowd
15 October 2021, 12:50pm
Want the best of VICE News straight to your inbox? Sign up here.
NBA star Kyrie Irving, a staunch supporter of all things police reform, social justice and Black equity, has become an unlikely hero to the right-wing, anti-vaccine crowd after getting benched over his decision to not get inoculated against COVID-19. And those who once called the star player an ally are not happy about it.
The Brooklyn Nets announced Tuesday that their star point guard would have to sit out the rest of the season for as long as he refrains from taking the most effective treatment for the deadly virus. The decision will cost Irving as much as $380,000 for every game he misses, cutting significantly into the more than $33 million he was expected to make this season. This was music to the ears of conservatives who jumped at the opportunity to use the Black man's star power to further the legitimacy of vaccine hesitancy and anti-mandate rhetoric.
"Kyrie just sacrificed more than Kaepernick ever did!," Donald Trump Jr. tweeted Tuesday, somehow comparing Irving to former NFL quarterback Colin Kaepernick, who started a global movement by kneeling for Black equality during the national anthem and gave up his career in the process.
"Black people need the freedom to be able to kneel at games during the national anthem, but they do not need the freedom to choose what substances are injected into their arms," Candace Owens tweeted. "BLM has their priorities straight."
An error occurred while retrieving the Tweet. It might have been deleted.
Given Irving's well-documented history of supporting progressive causes and charity, right's sudden affinity for him is strange. In 2020, he donated $1.5 million to WNBA players sitting out the season in support of Black Lives Matter and paid the tuition of students attending historically Black colleges. He bought a home for George Floyd's family and stood with the Standing Rock Sioux tribe as a vocal opponent of the Dakota Access Pipeline.
It's what makes conservatives' sudden support so frustrating, Judith Brown Dianis, the Executive Director of the Advancement Project National Office, told VICE News.
"The right-wing will always co-op Black people for their own agenda, finding these small open doors to use us."
"The right-wing will always co-op Black people for their own agenda, finding these small open doors to use us," Dianis said. "This is the tactic of the right-wing, white supremacy part of the Republican party. It's always looking for a Black person to be able to grab other Black people into their agenda."
People Are Mad as Hell About the NYPD's Plan to Hire 'Precinct Greeters'
Irving's decision and the NBA's protocols around the COVID-19 vaccine have been a lightning rod of controversy in some corners of the Black community. Michael Jordan, arguably the sport's most popular player, told NBC's Today that he is a "firm believer in science" and that he is "in total unison with the league" and their plans to prevent the spread of COVID-19 moving forward. In an op-ed written for Jacobin, Kareem Abdul-Jabbar called Irving's stance "irresponsible."
Abdul-Jabbar wrote that Irving "continues to reject the expertise of prominent immunologists without reason, contributing to vaccine hesitancy among people in the Black community, who are dying at twice the rate of white people. His lack of regard for Black lives doesn't deserve acceptance, nor does his lack of regard for the health and welfare of the NBA community."
Chanelle Helm, a lead core organizer of Louisville Black Lives Matter, said that her organization has advocated for the vaccines and all other alternatives that prevent the spread of COVID-19.
But pitting Irving against allies like Kaepernick is a form of slander in the broader movement around issues like police reform, Helm said, and shows a continued callousness towards what should matter most at this moment in history.
"Neither one of those two, Kyrie and Colin, asked to be brought up in that manner. It's really just disgusting," Helm said. "I think that's my frustration. They're doing whatever they can to make these divides, and that's evident when in their critique, in their commentary, in who they choose to praise, they're not giving any solace to the folks we have lost to this pandemic."
Irving doubled down on his choice to not take the vaccine on Instagram Live Wednesday night.
"Pay attention to what's going on out in the real world. People are losing their jobs to these mandates. People are having to make choices with their own lives which I respect," he said. "What would you do if you felt uncomfortable going into the season when you were promised that you would have exemptions or that you didn't have to be forced to get the vaccine? This wasn't an issue before the season started."
Reginald Thomas Brown, chair of the board of social justice organization Vocal NY in New York City, was one of the first 30,000 volunteers in the clinical trials for the Moderna vaccine. As a Black person, Brown hoped to reduce vaccine hesitancy in the Black community. Now he hopes Irving will reconsider his view on mandates.
"Ask him if he fastens his seat belt when he drives or gets on a plane. Ask him what he does when he gets to a red light," Brown said. "All of these are mandates. I mean I understand not wanting to be told what to do, but just about you. It's about the entire planet we're talking about."
Brown said that Irving should consider that his platform carries a lot of weight in the community.
"I understand the hesitancy," Brown said. "But you've probably already had the polio vaccine and the smallpox vaccine. And I'm sure you probably don't know what the ingredients of that were. If you're taking any kind of medication, you have no idea what's in there. Why is this any different?"
"The right are just looking for anything to justify what they're doing and will attach themselves to whatever they need to to attract attention," Brown said.
Regardless of where Irving stands on the COVID vaccine, Dianis just hopes he ends his silence on how the right has used his name.
"If you feel like you're being used for their disinformation campaigns, then you should speak up and stop that. Our responsibility should be to say I am not your puppet, I'm not your spokesperson, I'm not your poster child," Dianis said. "He's going to make a personal decision. But to me it's also a matter of not doing harm to our community. So when you make that personal decision, don't be used in the process for something that can hurt us more."
nba, Black Lives Matter, Race, Kyrie Irving, Coronavirus, covid
The NFL Has a Plan for Fewer COVID Cases: Less Testing
by Paul Blest
It Sure Seems Like Everyone Is Getting COVID. Here's What You Need to Know.
The NFL Is a COVID Superspreader Right Now
Sports Leagues Are Overrun With COVID. But They Are Playing On.
People Without COVID Are Dying Because Hospitals Are Full of Unvaxxed Patients
Mouthwash Does Not Kill COVID, According to Listerine
Novak Djokovic Is the New Face of the 'Unvaxxed Sperm' Movement
by David Gilbert
Glenn Beck Has COVID Again: 'It's Starting to Go Into My Lungs'


text:
Daily curiosities, history, people and more.
Conversations, Curiosities
Could you repeat that? Well, at least, they understand themselves. After all, Eliza Doolittle sounded natural to herself, before 'enry 'iggins tried to mold her into "a lady." Paul Kerswill,…
The Deadly Nyms
Acronyms, not to be confused with antonyms, synonyms, aptronyms, autonyms, tautonyms or pseudonyms, which I might need after this post, are abbreviations that are formed using the initial components in…
It All Adds Up. (Discounts, too.)
Products, Sales
August 21, 1888. William S. Burroughs patents the first successful adding machine. His first calculating machine (1885), had proved to be commercially impractical, but this '88 model brought him closer.…
The Second Pioneer
Americana, Contrarians
It was April 24, 1777, and Daniel Boone was in big trouble. About 100 Indians ambushed him outside Boonesborough. A gunshot wound broke his leg. As a Shawnee raised his…
A Satchel Full of Steamers
Americana, Rule Breakers, Style, Travel & Adventure
You'll recall our recent interview with singer-songwriter Jeffrey Foucault in which he talked with us about his new album, Blood Brothers. If you missed the interview, you can read it here. Jeffrey…
Getting to Be a Habit
Other people's working habits are always fascinating. I can sit and read about them for hours. Aristotle said: "We are what we repeatedly do. Excellence is therefore not an act…
Row, Row, Row Your Boat.
"Leander, Leander, Leander," cried the British. "Harvard, Harvard, Harvard," answered the Americans. The 1914 Harvard Second Varsity Eight nosed across the finish line ahead of the vaunted British club with…
Between Points A and B.
Curiosities, Travel & Adventure
Behold the beauty of maps. Utilitarian, certainly. But beyond that: works of art. The best objects in life can whop you with a double-whammy of usefulness and beauty. A sleek…


text:
namespace boost { namespace geometry
{

#ifndef DOXYGEN_NO_DETAIL
namespace detail { namespace is_valid
{

template
<
    typename Polygon,
    bool AllowDuplicates,
    bool CheckRingValidityOnly = false
>
class is_valid_polygon
{
protected:
    typedef debug_validity_phase<Polygon> debug_phase;

    template <typename InteriorRings>
    static bool has_valid_interior_rings(InteriorRings const& interior_rings)
    {
        return
            detail::check_iterator_range
                <
                    detail::is_valid::is_valid_ring
                        <
                            typename boost::range_value<InteriorRings>::type,
                            AllowDuplicates,
                            false, // do not check self-intersections
                            true // indicate that the ring is interior
                        >
                >::apply(boost::begin(interior_rings),
                         boost::end(interior_rings));
    }

    struct has_valid_rings
    {
        static inline bool apply(Polygon const& polygon)
        {
            typedef typename ring_type<Polygon>::type ring_type;

            // check validity of exterior ring
            debug_phase::apply(1);

            if ( !detail::is_valid::is_valid_ring
                     <
                         ring_type,
                         AllowDuplicates,
                         false // do not check self intersections
                     >::apply(exterior_ring(polygon)) )
            {
                return false;
            }

            // check validity of interior rings
            debug_phase::apply(2);

            return has_valid_interior_rings(geometry::interior_rings(polygon));
        }
    };

    // structs from partition -- start
    struct expand_box
    {
        template <typename Box, typename Iterator>
        static inline void apply(Box& total, Iterator const& it)
        {
            geometry::expand(total, geometry::return_envelope<Box>(*it));
        }

    };

    struct overlaps_box
    {
        template <typename Box, typename Iterator>
        static inline bool apply(Box const& box, Iterator const& it)
        {
            return !geometry::disjoint(*it, box);
        }
    };

    struct item_visitor
    {
        bool items_overlap;

        item_visitor() : items_overlap(false) {}

        template <typename Item1, typename Item2>
        inline void apply(Item1 const& item1, Item2 const& item2)
        {
            if ( !items_overlap
                 && (geometry::within(*points_begin(*item1), *item2)
                     || geometry::within(*points_begin(*item2), *item1))
                 )
            {
                items_overlap = true;
            }
        }
    };
    // structs for partition -- end

    template
    <
        typename RingIterator,
        typename ExteriorRing,
        typename TurnIterator
    >
    static inline bool are_holes_inside(RingIterator rings_first,
                                        RingIterator rings_beyond,
                                        ExteriorRing const& exterior_ring,
                                        TurnIterator turns_first,
                                        TurnIterator turns_beyond)
    {
        // collect the interior ring indices that have turns with the
        // exterior ring
        std::set<signed_index_type> ring_indices;
        for (TurnIterator tit = turns_first; tit != turns_beyond; ++tit)
        {
            if ( tit->operations[0].seg_id.ring_index == -1 )
            {
                BOOST_ASSERT( tit->operations[1].seg_id.ring_index != -1 );
                ring_indices.insert(tit->operations[1].seg_id.ring_index);
            }
            else if ( tit->operations[1].seg_id.ring_index == -1 )
            {
                BOOST_ASSERT( tit->operations[0].seg_id.ring_index != -1 );
                ring_indices.insert(tit->operations[0].seg_id.ring_index);
            }
        }

        signed_index_type ring_index = 0;
        for (RingIterator it = rings_first; it != rings_beyond;
             ++it, ++ring_index)
        {
            // do not examine interior rings that have turns with the
            // exterior ring
            if (  ring_indices.find(ring_index) == ring_indices.end()
                  && !geometry::covered_by(range::front(*it), exterior_ring) )
            {
                return false;
            }
        }

        // collect all rings (exterior and/or interior) that have turns
        for (TurnIterator tit = turns_first; tit != turns_beyond; ++tit)
        {
            ring_indices.insert(tit->operations[0].seg_id.ring_index);
            ring_indices.insert(tit->operations[1].seg_id.ring_index);
        }

        // put iterators for interior rings without turns in a vector
        std::vector<RingIterator> ring_iterators;
        ring_index = 0;
        for (RingIterator it = rings_first; it != rings_beyond;
             ++it, ++ring_index)
        {
            if ( ring_indices.find(ring_index) == ring_indices.end() )
            {
                ring_iterators.push_back(it);
            }
        }

        // call partition to check is interior rings are disjoint from
        // each other
        item_visitor visitor;

        geometry::partition
            <
                geometry::model::box<typename point_type<Polygon>::type>,
                expand_box,
                overlaps_box
            >::apply(ring_iterators, visitor);

        return !visitor.items_overlap;
    }

    template
    <
        typename InteriorRings,
        typename ExteriorRing,
        typename TurnIterator
    >
    static inline bool are_holes_inside(InteriorRings const& interior_rings,
                                        ExteriorRing const& exterior_ring,
                                        TurnIterator first,
                                        TurnIterator beyond)
    {
        return are_holes_inside(boost::begin(interior_rings),
                                boost::end(interior_rings),
                                exterior_ring,
                                first,
                                beyond);
    }

    struct has_holes_inside
    {
        template <typename TurnIterator>
        static inline bool apply(Polygon const& polygon,
                                 TurnIterator first,
                                 TurnIterator beyond)
        {
            return are_holes_inside(geometry::interior_rings(polygon),
                                    geometry::exterior_ring(polygon),
                                    first,
                                    beyond);
        }
    };

    struct has_connected_interior
    {
        template <typename TurnIterator>
        static inline bool apply(Polygon const& polygon,
                                 TurnIterator first,
                                 TurnIterator beyond)
        {
            typedef typename std::iterator_traits
                <
                    TurnIterator
                >::value_type turn_type;
            typedef complement_graph<typename turn_type::point_type> graph;

            graph g(geometry::num_interior_rings(polygon) + 1);
            for (TurnIterator tit = first; tit != beyond; ++tit)
            {
                typename graph::vertex_handle v1 = g.add_vertex
                    ( tit->operations[0].seg_id.ring_index + 1 );
                typename graph::vertex_handle v2 = g.add_vertex
                    ( tit->operations[1].seg_id.ring_index + 1 );
                typename graph::vertex_handle vip = g.add_vertex(tit->point);

                g.add_edge(v1, vip);
                g.add_edge(v2, vip);
            }

            debug_print_complement_graph(std::cout, g);

            return !g.has_cycles();
        }
    };

public:
    static inline bool apply(Polygon const& polygon)
    {
        if ( !has_valid_rings::apply(polygon) )
        {
            return false;
        }

        if ( CheckRingValidityOnly )
        {
            return true;
        }

        // compute turns and check if all are acceptable
        debug_phase::apply(3);

        typedef has_valid_self_turns<Polygon> has_valid_turns;

        std::deque<typename has_valid_turns::turn_type> turns;
        bool has_invalid_turns = !has_valid_turns::apply(polygon, turns);
        debug_print_turns(turns.begin(), turns.end());

        if ( has_invalid_turns )
        {
            return false;
        }

        // check if all interior rings are inside the exterior ring
        debug_phase::apply(4);

        if ( !has_holes_inside::apply(polygon, turns.begin(), turns.end()) )
        {
            return false;
        }

        // check whether the interior of the polygon is a connected set
        debug_phase::apply(5);

        return has_connected_interior::apply(polygon,
                                             turns.begin(),
                                             turns.end());
    }
};

}} // namespace detail::is_valid
#endif // DOXYGEN_NO_DETAIL

#ifndef DOXYGEN_NO_DISPATCH
namespace dispatch
{

// A Polygon is always a simple geometric object provided that it is valid.
//
// Reference (for validity of Polygons): OGC 06-103r4 (6.1.11.1)
template <typename Polygon, bool AllowSpikes, bool AllowDuplicates>
struct is_valid<Polygon, polygon_tag, AllowSpikes, AllowDuplicates>
    : detail::is_valid::is_valid_polygon<Polygon, AllowDuplicates>
{};

} // namespace dispatch
#endif // DOXYGEN_NO_DISPATCH

}} // namespace boost::geometry

#endif // BOOST_GEOMETRY_ALGORITHMS_DETAIL_IS_VALID_POLYGON_HPP

redpajama_set_name: RedPajamaGithub


text:
Balkanpokal steht für:

 Balkanpokal, europäischer Fußballwettbewerb für Vereinsmannschaften aus südosteuropäischen Ländern
 Balkanpokal (Frauen-Handball), Handballwettbewerb für Frauen-Nationalmannschaften
 Balkanpokal (Männer-Handball), Handballwettbewerb für Männer-Nationalmannschaften

Siehe auch:
 Balkan-Cup, von 1929 bis 1980 stattfindender Wettbewerb für Fußballnationalmannschaften der Balkanregion
 Balkan Cup

redpajama_set_name: RedPajamaWikipedia


This January, spoken arts label, Cadabra Records, will proudly bring you the first in a dedicated series collecting the best of author H.P. Lovecraft, with The Hound and The Music of Erich Zann.
2015 marks the 125th anniversary of the life of H.P. Lovecraft, the creative mastermind who helped attract countless souls into the realms of horror fiction for more than a century, responsible for the creation of timeless stories such as The Call of Cthulhu, At the Mountains of Madness, The Shadow Over Innsmouth, The Dunwich Horror, and many more.
With this, the first in an ongoing series for Cadabra Records, reader Andrew Leman brings to life two of the legendary American writer's stories, The Hound and The Music Of Erich Zann. Leman is a partner of the H.P. Lovecraft historical society, a professional actor with years of stage, screen, and audio performances including The Call of Cthulhu, The Whisperer in Darkness, and Dark Adventure Radio Theatre. Leman's voice captures the terror, dread, suspense, and madness permeating Lovecraft's writing. Additionally, the liner notes for the record were written by by S.T. Joshi who is a leading scholar on the writer and the author of H. P. Lovecraft: The Decline of the West (1990), I Am Providence: The Life and Times of H. P. Lovecraft (2010), Lovecraft and an Age In Transition (2014), and other critical and biographical works. With sound and effects handled by Hickey and the artwork commissioned to Alan Brown, The Hound and The Music of Erich Zann will mark the first time Lovecraft has been read on vinyl in over 35 years.
H.P. Lovecraft remains a master of the weird tale, his influence has spanned through generations of filmmakers, musicians, artists, and authors alike. Whether you've already read his work or are new to Lovecraft, we promise you will gasp in wonder to the horrors within. Dim the lights, close your eyes, and listen to some of the greatest tales of horror ever told.
Cadabra Records specializes the spoken arts — specifically, dark words in the vinyl format — and The Hound and The Music of Erich Zann will see an initial first pressing of 500 copies. The LP will be pressed on 150-gram vinyl and housed in a gatefold tip-on "old style" jacket, including a 4-page booklet with new liner notes and more. Pre-orders will be made available the first week of November and the album will ship out in January. Stand by for further details.


Since the introduction of its first compressor in 1958, JUN-AIR has become a leading supplier of quiet air compressors used in laboratories, dental surgeries, medical, beverage, graphic and industrial applications worldwide. Our products include a full range of standard and customised compressors and cabinets. Continuous development of products and production capabilities helps maintain JUN-AIR's solid reputation of quality and reliability among its more than half a million satisfied customers.
Quiet Air: The JUN-AIR oil-lubricated compressor is the "original" quiet compressor with a noise level below 45 dB(A) and is the lifeline of dental surgeries worldwide.
Quiet & Clean Air: Our oil-less rocking piston series is ideal for applications where noise and long life are key requirements.
Accessories: JUN-AIR offers a variety of options and replacement parts designed to maximise performance and ensure long system life.
Find a distributor in your region.


text:
def backup():
    def t3():
        import gdata.gauth
        # import webbrowser
        from selenium import webdriver
        from selenium.webdriver.support.ui import WebDriverWait
        from selenium.webdriver.common.by import By

        CLIENT_ID = '428607628598-dd19u5f3ma4rssk8sbm1ccjsbe3pq1ip.apps.googleusercontent.com'
        CLIENT_SECRET = 'fLOZ4Po28pAUB1wYA_WbsZql'
        SCOPE = 'https://www.google.com/m8/feeds/'
        USER_AGENT = 'Scarlett-AI'

        auth_token = gdata.gauth.OAuth2Token(client_id=CLIENT_ID, client_secret=CLIENT_SECRET, scope=SCOPE, user_agent=USER_AGENT)

        APPLICATION_REDIRECT_URI = 'http://localhost/oauth2callback'
        authorize_url = auth_token.generate_authorize_url(redirect_uri=APPLICATION_REDIRECT_URI)

        print(authorize_url)

        driver = webdriver.Chrome(executable_path="/usr/local/bin/chromedriver")
        driver.get(authorize_url)
        import time

        WebDriverWait(driver, 5).until(lambda driver: driver.find_element(By.ID, "identifierId"))
        username = driver.find_element_by_id("identifierId")
        username.send_keys("d.kanhar")

        WebDriverWait(driver, 5).until(lambda driver: driver.find_element(By.ID, "identifierNext"))
        driver.find_element_by_id("identifierNext").click()
        # time.sleep(10)

        try:
            WebDriverWait(driver, 5).until(lambda driver: driver.find_element(By.ID, "skipChallenge"))
            driver.find_element_by_id("skipChallenge").click()

            try:
                WebDriverWait(driver, 5).until(lambda driver: driver.find_element(By.ID, "password"))
                password = driver.find_element_by_name("password")
                password.send_keys("2NINitu!1")

                WebDriverWait(driver, 5).until(lambda driver: driver.find_element(By.ID, "passwordNext"))
                driver.find_element_by_id("passwordNext").click()

            except:
                WebDriverWait(driver, 5).until(lambda driver: driver.find_element(By.LINK_TEXT, "Enter your password"))
                driver.find_element_by_link_text("Enter your password").click()

                WebDriverWait(driver, 5).until(lambda driver: driver.find_element(By.ID, "password"))
                password = driver.find_element_by_name("password")
                password.send_keys("2NINitu!1")

                WebDriverWait(driver, 5).until(lambda driver: driver.find_element(By.ID, "passwordNext"))
                driver.find_element_by_id("passwordNext").click()
        except:
            WebDriverWait(driver, 5).until(lambda driver: driver.find_element(By.ID, "password"))
            password = driver.find_element_by_name("password")
            password.send_keys("2NINitu!1")

            WebDriverWait(driver, 5).until(lambda driver: driver.find_element(By.ID, "passwordNext"))
            driver.find_element_by_id("passwordNext").click()
        # time.sleep(10)

        WebDriverWait(driver, 5).until(lambda driver: driver.find_element(By.ID, "submit_approve_access"))
        driver.find_element_by_id("submit_approve_access").click()

        time.sleep(5)

        current_url = driver.current_url
        # print(current_url)
        import atom.http_core
        redirect_url = current_url
        url = atom.http_core.ParseUri(redirect_url)
        token = auth_token.get_access_token(url.query)
        # print(token)
        # print(auth_token)
        print(driver.current_url)

        import gdata.contacts.client

        client = gdata.contacts.client.ContactsClient(source='Scarlett-AI')
        query = gdata.contacts.client.ContactsQuery(max_results=10000)
        auth_token.authorize(client)
        feed = client.GetContacts(q=query)
        print(feed)
        # print(feed[0])

        from contactsFeedParser import GoogleContactsFeedParser
        parser = GoogleContactsFeedParser()
        print(100*"-")
        parser.parse_(message=feed)

        driver.quit()

        pass

    # t3()

import gdata.gauth
from selenium import webdriver
from selenium.webdriver.support.ui import WebDriverWait
from selenium.webdriver.common.by import By
import atom.http_core
import gdata.contacts.client
from contactsFeedParser import GoogleContactsFeedParser
import time
import creds as cr
import config as cfg

class FetchContacts(object):
    def __init__(self):
        self.CLIENT_ID = cr.CONTACTS_GOOGLE_AUTH_CLIENT_ID
        self.CLIENT_SECRET = cr.CONTACTS_GOOGLE_AUTH_CLIENT_SECRET
        self.SCOPE = cr.CONTACTS_GOOGLE_AUTH_SCOPE
        self.USER_AGENT = cr.CONTACTS_GOOGLE_AUTH_USER_AGENT
        self.APPLICATION_REDIRECT_URI = cr.CONTACTS_GOOGLE_AUTH_APP_REDIRECT_URI

        self.path_to_driver = cfg.PATH_To_CHROMEDRIVER

        self.username = cr.GOOGLE_UID
        self.password = cr.GOOGLE_PWD

        self.num_contacts = cfg.NUM_CONTACTS
        self.sleep_time = 5

        pass

    def fetch_(self):

        contacts = self.__driver()

        return contacts

    def __driver(self):

        self.auth_token = self.__authenticate_()
        self.__retry_browser()
        time.sleep(self.sleep_time)
        self.token = self.__parse_url()
        self.contactsFeed = self.__fetch_contacts()
        contacts = self.__parse_contacts()

        self.driver.quit()

        return contacts

    def __authenticate_(self):
        auth_token = gdata.gauth.OAuth2Token(client_id=self.CLIENT_ID, client_secret=self.CLIENT_SECRET,
                                             scope=self.SCOPE, user_agent=self.USER_AGENT)

        authorize_url = auth_token.generate_authorize_url(redirect_uri=self.APPLICATION_REDIRECT_URI)

        self.authorizw_url = authorize_url

        self.driver = self.__open_browser()
        self.driver.get(authorize_url)

        return auth_token

    def __open_browser(self):
        driver = webdriver.Chrome(executable_path=self.path_to_driver)
        return driver

    def __fetch_contacts(self):
        client = gdata.contacts.client.ContactsClient(source=self.USER_AGENT)
        query = gdata.contacts.client.ContactsQuery(max_results=self.num_contacts)
        self.auth_token.authorize(client)
        feed = client.GetContacts(q=query)
        return feed

    def __parse_contacts(self):

        parser = GoogleContactsFeedParser()
        parser.parse_(message=self.contactsFeed)
        contacts = parser.get_()

        return contacts

    def __retry_browser(self):
        # Currently expecting that the browser successfully authenticates itself in 2nd run, which might not be case.
        # We need to automate this till actually the run is succesfull.
        ret = False
        while True:
            try:
                ret = self.__authorize_from_browser()
            except:
                self.driver.quit()
                self.driver = self.__open_browser()
                self.driver.get(self.authorizw_url)

                ret = self.__authorize_from_browser()

            if ret:
                break
            else:
                continue

        return ret

    def __parse_url(self):
        current_url = self.driver.current_url

        redirect_url = current_url
        url = atom.http_core.ParseUri(redirect_url)
        token = self.auth_token.get_access_token(url.query)

        return token

    def __authorize_from_browser(self):
        WebDriverWait(self.driver, 5).until(lambda driver: driver.find_element(By.ID, "identifierId"))
        username = self.driver.find_element_by_id("identifierId")
        username.send_keys(self.username)

        WebDriverWait(self.driver, 5).until(lambda driver: driver.find_element(By.ID, "identifierNext"))
        self.driver.find_element_by_id("identifierNext").click()

        try:
            WebDriverWait(self.driver, 5).until(lambda driver: driver.find_element(By.ID, "skipChallenge"))
            self.driver.find_element_by_id("skipChallenge").click()

            try:
                WebDriverWait(self.driver, 5).until(lambda driver: driver.find_element(By.ID, "password"))
                password = self.driver.find_element_by_name("password")
                password.send_keys(self.password)

                WebDriverWait(self.driver, 5).until(lambda driver: driver.find_element(By.ID, "passwordNext"))
                self.driver.find_element_by_id("passwordNext").click()

            except:
                WebDriverWait(self.driver, 5).until(lambda driver: driver.find_element(By.LINK_TEXT, "Enter your password"))
                ret = self.driver.find_element_by_link_text("Enter your password").click()
                print(ret)

                WebDriverWait(self.driver, 5).until(lambda driver: driver.find_element(By.ID, "password"))
                password = self.driver.find_element_by_name("password")
                password.send_keys(self.password)

                WebDriverWait(self.driver, 5).until(lambda driver: driver.find_element(By.ID, "passwordNext"))
                self.driver.find_element_by_id("passwordNext").click()
        except:
            WebDriverWait(self.driver, 5).until(lambda driver: driver.find_element(By.ID, "password"))
            password = self.driver.find_element_by_name("password")
            password.send_keys(self.password)

            WebDriverWait(self.driver, 5).until(lambda driver: driver.find_element(By.ID, "passwordNext"))
            self.driver.find_element_by_id("passwordNext").click()

        WebDriverWait(self.driver, 5).until(lambda driver: driver.find_element(By.ID, "submit_approve_access"))
        self.driver.find_element_by_id("submit_approve_access").click()
        return True

if __name__ == '__main__':
    obj = FetchContacts()
    contacts = obj.fetch_()
    print(contacts)


This is not only my first read in the Bachelor Brotherhood series, but my first Denise Grover Swank read ever.
Lanie and Tyler are the eternal bachelor and bachelorette, ever the commitment phobes, workaholics - you get the drill.
Until each other that is.
I adore the spark between them, from the first maiming till the last word. However they did frustrate me at times, particularly Lanie.
I think it was her workaholic tendencies, and her refusal to deviate from that. I could kind of understand it, but girl, you need to live a little.
Tyler was all kinds of swoony and romantic and lovely. Psycho hose beast exes and all.
Now, since I haven't read the first book, I can only go by her character in this second installment - What the hell Britt?? You may be all cute in the first book, but 95% of the time in Until You, I really, really disliked you. I wanted to tell you off for everyone else in the book. You grated on me and made it quite unpleasant to continue reading at times - but this could just be me.
I was Lanie and Tyler's big cheerleader as I was reading. I wanted them to pull their heads out and work on it, make it happen people!
Ms Swanks writing was good, the story flowed well, and I will be reading more of her in the future.


AUSTRAC will up the ante in its case against the Commonwealth Bank of Australia, with the transactions regulator expecting to file fresh allegations on Thursday that it breached the law 100 additional times while facilitating banking by criminal syndicates involved in money laundering and terrorist financing.
Commonwealth Bank filed its defence to AUSTRAC's original allegations on Wednesday, admitting it was late filing 53,506 threshold transaction reports "which all resulted from the same systems related error". It also admitted it "did not adequately adhere to risk assessment requirements for intelligent deposit machines" although it disputes the number of contraventions.
CBA admits that it did not undertake a separate money laundering and terrorism financing risk assessment on its intelligent deposit machines prior to their roll-out in May 2012. Assessment of the risks conducted by the bank in July 2015, July 2016 and October 2017 found the inherent risk borne by the machines was "high".
The bank acknowledges it should have introduced daily limits on cash deposits in light of information by January 2016 to mitigate the risks. The bank did not introduce daily deposit limits until November 2017. The bank says due to an error in the process of merging systems automated monitoring failed to operate as intended across 778,370 accounts.
CBA also said it will admit in whole or part 91 of the allegations failures to supply "suspicious matter reports" but will deny a further 83 of AUSTRAC's allegations, and admit in whole or part 52 of the allegations concerning ongoing requirements to conduct customer due diligence but deny a further 19 of them.
CBA said that AUSTRAC has indicated that it proposes to file an amended statement of claim in the Federal Court containing additional alleged contraventions. The bank was required to report transactions involving amounts over $10,000 as well as suspicious activities.
"If an amended claim is served on us, we expect the court would set a timetable for CBA to file an amended defence. We will provide market updates as appropriate," the bank said.
The bank says it takes its obligations seriously and accepts the importance of the legislation. It says it "accepts that the failure to issue TTRs and SMRs in accordance with the act has deprived law enforcement of some additional intelligence".
It is understood that AUSTRAC's amended claim relates to additional contraventions that came to light after the original statement of claim was lodged with the Federal Court in August.
The expected 100 additional allegations may include new information that CBA breached its anti-money laundering and counter terrorism financing obligations relating to individuals with connections to known terrorist organisations, and will allege new connections with criminal syndicates laundering money out of Australia.
There may also be additional allegations relating to failure to report suspicious matters within required timeframe, and breaches of customer due diligence relating to customer identity.
CBA has pointed to a "program of action" which it says has addressed issues that AUSTRAC alleges were ongoing contraventions in its claim. It says it has closed 4000 accounts between July 1, 2012 and July 31, 2017.
The initial revelation of the alleged breaches by AUSTRAC in August triggered dramatic actions by the CBA board and other regulators. New chair Catherine Livingstone slashed the senior executive team's short-term bonuses to zero and pulled forward an announcement that chief executive Ian Narev would retire by mid next year once a successor is found.
The claims also prompted the Australian Prudential Regulation Authority to launch a review into the bank's risk culture, which will report next year. CBA is also facing a shareholder class action and, potentially, a case by the corporate regulator relating to continuous disclosure.


text:
Estyn Inspection 2018 Information
The advantages of being bilingual
School Based Counselling Service
Personal & Social Education
Science KS3 & KS4
Science AS / A2
Additional Learning Needs Department
Welsh Baccalaureate
Pupils ▼
Parents ▼
Information to Parents Booklet 19/20
School Admissions website
School Uniform & Parents Guide
Class Charts
Cafeteria Price Lists
Pupil Deprivation Grant
Change of Contact Details
Bullying – Parent & Pupil Guide
Emlyn News
Carmarthen Art Trip
Carmarthen Art Trip On Friday 8th February, a selection of pupils from the More Able & Talented in Art group attended a workshop in the Oriel Myrddin, Carmarthen. In January, the gallery launched 'The Building Project', a participatory installation where members of the local community create plaster casts of houses for display...
Art Trip
On Friday 12th January 2018, students of Art and Photography from Years 10 to 13, took part in a one day educational trip to see two London galleries in preparation for their upcoming Examination Unit as well as enhancing their Contextual Understanding. The first stop was the Saatchi gallery in Chelsea where pupils were...
London Art Trip
On Friday, 13th January 2017, students of Art and Photography from Years 10 to 13, took part in a one day educational trip to see two London galleries in preparation for their upcoming examination theme as well as enhancing their contextual understanding. The first stop was the Saatchi gallery in Chelsea where pupils were given a guided talk...
Welsh Woollen Museum
At the beginning of the Autumn term, Art and Photography students from Years 12 and 13 visited the National Wool Museum in Drefach Felindre. This was arranged to give students a positive start to their AS coursework studies, utilising a local industry in order to gain precious first hand research. Over two days, after an informative tour of the...
On Thursday 7th of July, Year 10 GCSE Art and Year 12 photography students visited The National Botanical Gardens where they had the opportunity to undertake essential first hand observational drawings as well as taking photographs as an introduction to the theme of 'Natural Forms'. Pupils marvelled at the world's largest single-span glasshouse, The Great Glasshouse, as well...
During the summer, Year 12 Art and Photography students were kindly invited by the Rhod Artists Group to participate in a series of workshops at their base at Melin Glonc in Drefelin, Llandysul. Several visiting contemporary artists worked with students to create temporary experimental sculptures which investigated the limitations and/or extensive possibilities of even...
Art Competition Winner
The Art department is pleased to announce the winner of this year's Eisteddfod Art competition is Year 7 pupil Promise Fulstow. Promise created her composition in response to the work of Ogwyn Davies who was born and lived in Tregaron. His work often includes the use of paint, words, symbols and figurative elements to create a...
The Art department is delighted to announce an exciting opportunity for pupils to be able to showcase their work as our school has now registered for the Royal Academy of Arts Summer exhibition 2016. The A-level Summer Exhibition Online is the only open submission online exhibition for emerging artists aged 16 to 18 years...
Art & Photography students visit the National Wool Museum
At the beginning of the Autumn term, Art and Photography students from Year 12 visited the National Wool Musuem in Dre-fach Felindre. This was arranged to give students a positive start to their AS coursework studies, utilising a local industry in order to gain precious first hand research. Over two days, after an informative...
Art students visit the National Botanic Gardens
On Thursday 25th June, Year 10 GCSE Art students visited The National Botanical Gardens where they had the opportunity to undertake essential first hand observational drawings as well as taking photographs as an introduction to the theme of 'Natural Forms'. Pupils marvelled at the world's largest single-span glasshouse, The Great Glasshouse, as well as discovering the unusual, often...
The Art Department at Ysgol Gyfun Emlyn is very well established and recognised as being one of the strongest in the area. Staff are well qualified and experienced as well as being practising artists who have worked together as a successful team for a number of years.
Our students constantly perform well in public examinations and are also successful in regional and National competitions. The work of the department has also been featured in National newspapers, radio and television. Students' work has also featured in exhibitions in Wales and Ireland as part of a European cultural exchange programme.
We have forged strong links with a number of contemporary artists, designers and craftspeople. These individuals readily offer their time and expertise to assist our students with varying aspects of their work as well as offering work experience and opportunities. Among these artists are Aneurin Jones (painter), David Beattie (etcher), Pete Davis (photographer), Seb Boyesen (sculptor), Paul Clarke (carver) and Yoka Kilkelly (potter). We also have strong links with The National Woollen Museum, The Welsh Wildlife Centre and the Welsh Museum of Childhood. These centres have been used as venues for practical workshops often given by guest practicioners. They are also used for research for various projects.
Many of our students opt to continue with their art education after completing their examinations. We have an excellent relationship with Coleg Sir Gar and members of their art staff regularly visit the school to offer advice on courses and career opportunities
Some former students are making a name for themselves as artists and they frequently acknowledge the contribution that their experiences with us has made to their careers. To name one who is currently making a name for herself is Eloise Govier whose work is selling at major galleries in London, New York and Tokyo.
For a small school this is a big department.
Tweets by ygemlyn
Ysgol Gyfun Emlyn
SA38 9LN
Email: admin@emlyn.carms.sch.uk
Multilingual functionality is provided by WPML
© Ysgol Gyfun Emlyn 2019